These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels. Knable MB; Heinz A; Raedler T; Weinberger DR Psychiatry Res; 1997 Sep; 75(2):91-101. PubMed ID: 9351491 [TBL] [Abstract][Full Text] [Related]
6. A biological basis for the sex bias of antipsychotic drugs adverse events. Gurwitz D; Morag A; Oved K J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507 [No Abstract] [Full Text] [Related]
7. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. Boettger S; Jenewein J; Breitbart W Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389 [TBL] [Abstract][Full Text] [Related]
10. Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol. Moleman P; Janzen G; von Bargen BA; Kappers EJ; Pepplinkhuizen L; Schmitz PI Am J Psychiatry; 1986 Feb; 143(2):232-4. PubMed ID: 3946663 [TBL] [Abstract][Full Text] [Related]
12. Parkinsonism by haloperidol and piribedil. Corsini GU; Del Zompo M; Spissu A; Mangoni A; Gessa GL Psychopharmacology (Berl); 1978 Oct; 59(2):139-41. PubMed ID: 103114 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. De Deyn PP; Rabheru K; Rasmussen A; Bocksberger JP; Dautzenberg PL; Eriksson S; Lawlor BA Neurology; 1999 Sep; 53(5):946-55. PubMed ID: 10496251 [TBL] [Abstract][Full Text] [Related]
14. Haloperidol and thioridazine in treatment of chronic schizophrenics. Prasad L; Townley MC Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664 [No Abstract] [Full Text] [Related]
15. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596 [TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine. Gerlach J; Simmelsgaard H Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110 [No Abstract] [Full Text] [Related]
17. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol. Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088 [TBL] [Abstract][Full Text] [Related]
18. [Tacrine: first generation of anti-dementia drugs]. Cacabelos R Med Clin (Barc); 1995 Jun; 105(3):105-15. PubMed ID: 7603108 [No Abstract] [Full Text] [Related]
19. [Tacrine in Alzheimer's disease]. López de Munain A Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671 [No Abstract] [Full Text] [Related]
20. The pharmacotherapy of Tourette syndrome. Caine ED Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970 [No Abstract] [Full Text] [Related] [Next] [New Search]